TRUQAP 200 mg/1
capivasertib · TABLET, FILM COATED · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
TRUQAP is a tablet, film coated containing capivasertib at 200 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- TRUQAP
- Generic Name
- capivasertib
- NDC Code (Product)
0310-9501- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218197
- Marketing Start
- 11/16/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is TRUQAP used for?
TRUQAP contains capivasertib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is TRUQAP a controlled substance?
TRUQAP is not classified as a controlled substance by the DEA.
What is the generic name for TRUQAP?
The generic name for TRUQAP is capivasertib. There are no other listed brand versions of capivasertib.
What is the NDC code for TRUQAP 200 mg/1?
The NDC (National Drug Code) for TRUQAP 200 mg/1 is 0310-9501, listed by AstraZeneca Pharmaceuticals LP.
Other TRUQAP Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)